CIRCULATING TUMOUR CELLS INDICATE THE PRESENCE OF RESIDUAL DISEASE POST-CASTRATION IN PROSTATE CANCER PATIENT-DERIVED XENOGRAFT MODELS

Circulating Tumour Cells Indicate the Presence of Residual Disease Post-Castration in Prostate Cancer Patient-Derived Xenograft Models

Castrate-resistant prostate cancer (CRPC) is the hdw1620dnpk lethal form of prostate cancer.Epithelial mesenchymal plasticity (EMP) has been associated with disease progression to CRPC, and prostate cancer therapies targeting the androgen signalling axis, including androgen deprivation therapy (ADT), promote EMP.We explored effects of castration on

read more